DK0950113T3 - Detektion af genetisk prædisposition for synstruende diabetisk retinopati - Google Patents

Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Info

Publication number
DK0950113T3
DK0950113T3 DK97944986T DK97944986T DK0950113T3 DK 0950113 T3 DK0950113 T3 DK 0950113T3 DK 97944986 T DK97944986 T DK 97944986T DK 97944986 T DK97944986 T DK 97944986T DK 0950113 T3 DK0950113 T3 DK 0950113T3
Authority
DK
Denmark
Prior art keywords
diabetic retinopathy
vision
detection
genetic predisposition
identified
Prior art date
Application number
DK97944986T
Other languages
Danish (da)
English (en)
Inventor
Gordon Duff
Ian Rennie
Robert Richardson
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of DK0950113T3 publication Critical patent/DK0950113T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Catching Or Destruction (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97944986T 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati DK0950113T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621129.7A GB9621129D0 (en) 1996-10-10 1996-10-10 Detecting genetic predisposition to sight-threatening diabetic retinopathy
PCT/GB1997/002790 WO1998015653A1 (fr) 1996-10-10 1997-10-09 Detection de la predisposition genetique a la retinopathie diabetique avec risque d'atteinte de la vision

Publications (1)

Publication Number Publication Date
DK0950113T3 true DK0950113T3 (da) 2003-01-27

Family

ID=10801212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944986T DK0950113T3 (da) 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Country Status (12)

Country Link
US (1) US6713253B1 (fr)
EP (1) EP0950113B1 (fr)
AT (1) ATE224456T1 (fr)
AU (1) AU742957B2 (fr)
CA (1) CA2267155C (fr)
DE (1) DE69715669T2 (fr)
DK (1) DK0950113T3 (fr)
ES (1) ES2186926T3 (fr)
GB (1) GB9621129D0 (fr)
IL (1) IL129390A (fr)
WO (1) WO1998015653A1 (fr)
ZA (1) ZA979071B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
AU769949B2 (en) * 1998-04-21 2004-02-12 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
EP1252895A4 (fr) * 2000-01-31 2003-04-16 Santen Pharmaceutical Co Ltd Remedes pour troubles ophtalmiques
GB0009294D0 (en) * 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
CN1753903B (zh) * 2001-11-19 2010-05-12 白介素遗传公司 影响转录和对炎性和传染性疾病的敏感性的白细胞介素-1基因座的功能多态性
KR100924468B1 (ko) 2002-01-25 2009-11-03 인터레우킨 제네틱스, 인코포레이티드 Ｉｌ-1 유전자 집단 및 관련된 염증성 다형성과 일배체형
CN1711361A (zh) * 2002-10-15 2005-12-21 诺瓦提斯公司 预测药物治疗副效应水肿的方法
JP2007501627A (ja) * 2003-08-08 2007-02-01 インタールーキン ジェネティックス インク 骨粗鬆症のための診断法および治療法
GB0417763D0 (en) * 2004-07-09 2004-09-08 Sec Dep For The Home Departmen Improvements in and relating to the investigation of dna samples
US8105775B2 (en) 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US20090053816A1 (en) * 2006-03-24 2009-02-26 University Of Louisville Research Foundation, Inc. Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders
US20090222212A1 (en) * 2006-04-03 2009-09-03 Forensic Science Services Ltd. analysis of mixed source dna profiles
US20110092446A1 (en) * 2007-07-20 2011-04-21 Cedric Francois Compositions and methods for treatment of trauma
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
JP2011502510A (ja) * 2007-11-08 2011-01-27 インタールーキン ジェネティクス， インコーポレイテッド 老化に関係がある皮膚疾患の診断
WO2009135219A2 (fr) * 2008-05-02 2009-11-05 Interleukin Genetics, Inc. Détection d'une prédisposition génétique à des états associés à l'ostéoarthrite
EP2283156B1 (fr) * 2008-05-02 2015-11-11 Interleukin Genetics, Inc. Détection de prédisposition génétique à des pathologies associées à l'arthrose
JP2019503176A (ja) 2016-01-12 2019-02-07 インターロイキン ジェネティクス， インコーポレイテッド 処置に対する応答を予測するための方法
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CA3142662A1 (fr) 2019-06-06 2020-12-10 Sitokine Limited Compositions et methodes de traitement des carcinomes pulmonaires, colorectaux et mammaires
WO2021028469A1 (fr) 2019-08-12 2021-02-18 Sitokine Limited Compositions et méthodes de traitement du syndrome de libération de cytokines et de neurotoxicité
WO2021205013A1 (fr) 2020-04-09 2021-10-14 Sitokine Limited Compositions et méthodes de traitement de la covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687064T2 (de) 1985-06-14 1993-11-11 Bristol Myers Squibb Co Verfahren zur identifizierung von mit gesteigerter diabetesgefahr assoziierten allelen.
US5039606A (en) 1987-10-29 1991-08-13 Virginia Mason Research Center Diagnostic probe for diabetes type I predisposition
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5698399A (en) 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
AU742957B2 (en) 2002-01-17
GB9621129D0 (en) 1996-11-27
ATE224456T1 (de) 2002-10-15
DE69715669D1 (de) 2002-10-24
AU4631197A (en) 1998-05-05
ZA979071B (en) 1998-07-08
ES2186926T3 (es) 2003-05-16
IL129390A (en) 2002-05-23
DE69715669T2 (de) 2003-09-18
EP0950113A1 (fr) 1999-10-20
CA2267155A1 (fr) 1998-04-16
IL129390A0 (en) 2000-02-17
US6713253B1 (en) 2004-03-30
EP0950113B1 (fr) 2002-09-18
WO1998015653A1 (fr) 1998-04-16
CA2267155C (fr) 2003-07-08

Similar Documents

Publication Publication Date Title
GB9621129D0 (en) Detecting genetic predisposition to sight-threatening diabetic retinopathy
Dombrowski et al. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles
ATE429511T1 (de) Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
NO980439L (no) Detektering av genetisk predisposisjon for periodontal sykdom
DE69724209D1 (de) Erkennung einer genetischen prädisposition fur osteoporose
WO2001090419A3 (fr) Methodes d'analyse genetique d'adn servant a detecter des variances de sequence
DE69029018D1 (de) Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse
WO2002086163A8 (fr) Procedes d'analyse genomique a haut rendement mettant en oeuvre des microreseaux etiquetes au niveau de sites de restriction
WO2000050872A3 (fr) Systeme de criblage cellulaire
DK1131471T3 (da) Et system til cellebaseret screening
WO2001001218A3 (fr) Obtention et utilisation de donnees sur les haplotypes
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
DE69704031D1 (de) Test zur diagnose eines erhöhten brustkrebs-risikos
ATE361378T1 (de) Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben
WO2001026029A3 (fr) Procede et systeme permettant de fournir sur un reseau informatique des renseignements cliniques sur le genotype
WO2001004349A3 (fr) Diagnostic ou pronostic de la maladie d'alzheimer et composition therapeutique pour la prevention ou le traitement de la maladie d'alzheimer
ATE419380T1 (de) Bestimmung des kollagen genotyps
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
WO2005049866A3 (fr) Procede de detection de la maladie de charcot-marie de type 2a
WO2002053018A3 (fr) Procede d'identification et de gestion de l'augmentation des risques de cancer du sein associes a des polymorphismes des genes mhc
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
MX9600860A (es) Metodo para detectar polimorfismo de gen p4501a2 de citocromo humano.
WO2002090585A3 (fr) Marqueur genetique
WO2005058931A3 (fr) Procedes et algorithmes permettant d'identifier des sites genomiques regulateurs
CA2263712A1 (fr) Methodes permettant de diagnostiquer et d'evaluer une predisposition aux troubles bipolaires de l'humeur